Marketwatch Panacea Biotec soars 17% after company signs deal to produce Sputnik V vaccine doses Admin April 6, 2021 Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF, a joint statement said. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
